Standout Papers

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy 2025 202612
  1. Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy (2025)
    Sikai Ling, Xue Zhang et al. Nature Nanotechnology

Immediate Impact

3 by Nobel laureates 18 from Science/Nature 81 standout
Sub-graph 1 of 22

Citing Papers

Lactate: A key regulator of the immune response
2025 Standout
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
11 intermediate papers

Works of Mike Firth being referenced

Engineered Cas9 extracellular vesicles as a novel gene editing tool
2022
Delivering Robust Candidates to the Drug Pipeline through Computational Analysis of Arrayed CRISPR Screens
2020
and 5 more

Author Peers

Author Last Decade Papers Cites
Mike Firth 433 48 115 49 23 536
Raphaela Fritsche‐Guenther 407 50 86 31 25 549
Binsheng Gong 464 55 230 50 35 600
Alberto Calderone 509 98 57 41 16 622
Ammar Ammar 344 55 87 40 12 546
Lujia Chen 338 61 110 70 34 558
Alexey Dementiev 252 21 193 57 18 537
Junmei Cairns 361 49 128 54 26 580
Yudong Wang 340 70 112 34 26 530
Sai Mukund Ramakrishnan 352 25 58 58 26 557
Taejeong Bae 480 78 169 124 22 625

All Works

Loading papers...

Rankless by CCL
2026